FCM
TMDX icon

Fieldview Capital Management’s Transmedics TMDX Stock Holding History

Fieldview Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,045
Closed -$1.34M – 708
2025
Q4 		$1.34M Sell
11,045
-4,246
-28% -$533K 0.23% 150
2025
Q3 		$1.72M Buy
+15,291
New +$1.79M 0.28% 129

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fieldview Capital Management's TMDX Position: Q1 2026 in Review

Fieldview Capital Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 11,045 shares — an estimated $1.34M sold.

Fieldview Capital Management first reported a position in TMDX in Q3 2025 and held it in 2 quarters. The position peaked at $1.72M in Q3 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Fieldview Capital Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 11,045 Transmedics shares in Q1 2026, an estimated $1.34M.
  • Fieldview Capital Management first reported a position in Transmedics in Q3 2025 and held it in 2 quarters.
  • Fieldview Capital Management's Transmedics position peaked at $1.72M in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.